Irrespective of the market trend, smart investors neither throw caution to the wind nor do they get butterflies in their stomach. How do they manage this? We caught up with Sandeep Tandon, Director and CEO, Quant Mutual Fund recently to find out the answer.
Read more
In the last one year, a whopping 1051 schemes have applied for IPOs, of which only 582 schemes are currently holding on to those IPOs’ shares.
Read more
Parag Parikh Flexi Cap Fund plays various overarching themes through just one scheme, making it one of the most comprehensive yet rewarding offerings.
Read more
The macro-economic risk in the pharma sector is comparatively lower than other sectors. This is because irrespective of how macroeconomic variables – interest rate, GDP and inflation – move, the need for medication and healthcare services is unaffected.
Read more
Nippon India Pharma Fund appears well-positioned to take advantage of the under penetration of pharmaceuticals and healthcare services in India and other emerging markets. The fund’s penchant for companies catering to specialty businesses in the developed markets might prove handsomely rewarding in the long run.
Read more
Investing in overseas markets helps you hold assets denominated in foreign currencies which, in a way, offers you a hedge against the potential weakness in the Rupee.
Read more